Showing 9,781 - 9,800 results of 30,730 for search '(( 2 step decrease ) OR ( 50 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.12s Refine Results
  1. 9781
  2. 9782

    Stringent selection of features related to Cell Speed and or Corrected Membrane Dynamics. by Jacob M. Kowalewski (780662)

    Published 2015
    “…(C) The features were categorized by whether they contributed to each separation, as well as whether they showed a significant difference between groups (determined via Kruskal-Wallis multiple group testing). According to this two-step criteria, 15 variables contributed to a difference only between Cell Speed related groups, 7 variables contributed to the difference between CMD related groups only and 33 variables contributed to both Cell Speed and CMD related differences. …”
  3. 9783
  4. 9784

    Water immersion and one-year storage influence the germination of the pyrenes of Copernicia alba Morong, a palm tree from a neotropical wetland by Vanessa Couto Soares (14189614)

    Published 2022
    “…Data on seed dormancy and storage have been neglected for many native palm species in Brazil. Therefore, we investigated the effect of water treatments and one-year storage on the germination of Copernicia alba Morong, a palm tree from the Brazilian Pantanal wetland. …”
  5. 9785

    HTRF for high-throughput screening of HCMV NEC inhibitors. by Han Chen (228557)

    Published 2023
    “…The HTRF ratio for the NEC (signal, S) was ~3-fold higher than the background (B) HTRF ratios for His-UL50 or Myc-UL53 alone (S/B ~3). Untagged UL50 decreased S/B to near background levels, serving as a positive control, while UL50_E56A, which is highly defective for UL53 binding [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011781#ppat.1011781.ref012" target="_blank">12</a>] did not decrease S/B, serving as a negative control. …”
  6. 9786
  7. 9787
  8. 9788
  9. 9789
  10. 9790
  11. 9791

    Supplementary Material for: Five-Year Therapy with Recombinant Human Insulin-Like Growth Factor-1 in a Patient with PAPP-A2 Deficiency by Muthuvel G. (14430801)

    Published 2023
    “…We describe five-year treatment response to recombinant human IGF-1 (rhIGF-1) in a patient with PAPP-A2 deficiency, and the phenotype of PAPP-A2 deficiency in three siblings. …”
  12. 9792

    Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  13. 9793

    Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  14. 9794

    Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  15. 9795

    Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  16. 9796

    Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
  17. 9797

    Patterns in Species Persistence and Biomass Production in Soil Microcosms Recovering from a Disturbance Reject a Neutral Hypothesis for Bacterial Community Assembly by Fen-Guo Zhang (736948)

    Published 2015
    “…In microcosms recovering from the disturbance, however, species diversity decreased dramatically (by > 50%); and in most cases there was not a positive relationship between species initial abundance and their chance of persistence. …”
  18. 9798
  19. 9799
  20. 9800

    Gonadal development and sex ratios as a function of TL. by Frederic H. Martini (481487)

    Published 2013
    “…</p> <p>(b) Sex ratios (female:male) as a function of TL. Data were sorted into 50 mm TL intervals. …”